Need Help? Chat Now With a Live Representative!

ARG Conference News: ASPHO 2019 in New Orleans May 1-4

ARG Conference News: ASPHO 2019 in New Orleans May 1-4

ARG Conference News: ASPHO 2019 in New Orleans May 1-4

April 23, 2019

Two ARG team members will be attending the 2019 ASPHO Conference in New Orleans May 1-4. ARG has deep experience in and ongoing commitment to oncology CRO services, and two of our organizational keys to successful project delivery are initial planning and then ongoing robust communication.
 Jennifer Prichard, MD, Medical Monitor

"The more thought and expertise that is put into the trial at the beginning, the better the data will be at the end. Often oncology trials will be quite complicated and have a long follow-up period. ARG has worked extensively in the rare disease and oncology space, gaining the experience to handle complicated protocols."

Jennifer
Shay Brill, MS, Vice-President of Strategy and Client Relations

"Our teams work well together due to many reasons, but continuity stands out. This familiarity drives effective and continual communication, allowing teams to complete tasks and hit timelines, ultimately delivering high quality deliverables."

Shay Brill
Jen and Shay are looking forward to connecting with other ASPHO attendees to share pediatric clinical trial best practices during the four days they will be in New Orleans. Please contact clofrese@atlanticresearchgroup.com to arrange a conversation.

The Vital Role of Team Stability in Advancing Clinical Trials

The Vital Role of Team Stability in Advancing Clinical Trials

In the fast-paced world of clinical research, turnover rates are high and project continuity can be a challenge. However, at […]

March 29, 2024
Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024
ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

CHARLOTTESVILLE, VIRGINIA – ARG (Atlantic Research Group) proudly announces its ongoing collaboration with Humacyte, a leading biotechnology company, on the […]

February 23, 2024
GO TO TOP